| As you may have noticed, on June 1st the DEA recently made effective the electronic prescribing of controlled substances. This is great news for the entire Health IT industry and OA Systems applauds the DEA for taking these much anticipated steps. This will definitely help overcome one of the major hurdles for e-prescribing. However, because of the complexity of the criteria set forth by the DEA for certification of both prescriber and pharmacy applications, it may take a while before the industry actually sees the electronic transmission of controlled substances.
We at OA Systems are currently exploring what needs to be altered in RxCure, our patented e-prescribing software, in order to allow for the electronic transmission of controlled substances. Because these changes may take some time, we cannot determine when you will be able to prescribe controlled substances electronically through RxCure. However, we will keep you updated through our communication streams such as our newsletter and blog. Thank You for your understanding. If you have any questions, please feel free to contact us. For further information, please see FAQs from the DEA and Surescripts Statement on DEA Interim Final Rule. |
|
Categories
Tag Cloud
ama
american medical association
ARRA
Billing
Brian Ahier
claimscure
CMS
Controlled Substances
DEA
E-Prescribing
EHR
electronic billing
Electronic Health Records
Electronic Medical Records
electronic prescribing
electronic prescription
EMR
freedom
happiness
healthcare
Health IT
HHS
HITECH
incentives
Meaningful Use
Medicaid
medical billing
ncpa
OA Systems
ONC
prescription software
Regina Holliday
technology
Posts Tagged ‘electronic prescribing’
The Intricacies of E-prescribing Controlled Substances
New York State Medicaid Offers Incentive For E-Prescribing
The New York State Medicaid has rolled out its electronic prescribing incentive program this month.
While the HITECH ACT is taking shape, New York wants to accelerate the adoption of technology in healthcare. Isn’t it nice to have forward thinking states such as New York?
This incentive program offers Medicaid prescribers $0.80 per dispensed ambulatory Medicaid e-prescription. In addition, pharmacies are going to benefit financially by receiving $0.20 per dispensed ambulatory Medicaid e-prescription. Any enrolled physician (MD, DO), Dentist, NP, Podiatrist, Optometrist, and licensed Midwife is eligible. Furthermore, this program is going to promote patient medication adherence, because the incentive is payable when the prescription is dispensed to the beneficiary. All prescriber incentives are going to be bundled into quarterly payments.
This program should encourage other states (California, I can’t see you!) to promote healthcare technology as New York is certainly doing its part in promoting the early adoption of technology in healthcare.
Impact of Controlled Substances on E-Prescribing
A lot of times we come across doctors who are interested in e-prescribing but when they explore the technology in depth to find a comfortable fit, some find out that they are unable to prescribe scheduled drugs through any of the e-prescribing solutions.
Federal and state governments as well as the private sector are investing tens of billions of dollars to push e-prescribing and EHR technologies past the tipping point. With so much momentum building towards e-prescribing and EHR, the DEA will finally allow doctors to prescribe scheduled drugs electronically this summer.
What will this mean for doctors? A lot of practitioners from psychiatrists to pain management doctors will now gush towards embracing e-prescribing which will help the health IT industry move closer to the tipping point.
